Osteoarthritis

Showing NaN - NaN of 55

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Osteoarthritis, Pain Trial in Worldwide (Placebo, Fulranumab 1 mg, Fulranumab 3 mg)

Completed
  • Osteoarthritis
  • Pain
  • Placebo
  • +3 more
  • Birmingham, Alabama
  • +52 more
Sep 25, 2017

Osteoarthritis Trial in United States (CNTX-4975, Placebo)

Completed
  • Osteoarthritis
  • Birmingham, Alabama
  • +21 more
Aug 3, 2017

Osteoarthritis Trial in United States (CR845 0.25 mg, CR845 0.50 mg, CR845 1 mg)

Completed
  • Osteoarthritis
  • CR845 0.25 mg
  • +3 more
  • Omaha, Nebraska
  • +4 more
Jan 30, 2017

Osteoarthritis Trial in Worldwide (SD-6010, Placebo)

Completed
  • Osteoarthritis
  • Birmingham, Alabama
  • +182 more
Nov 1, 2016

Osteoarthritis Trial in United States (Meloxicam Test Capsules)

Completed
  • Osteoarthritis
  • Meloxicam Test Capsules
  • Birmingham, Alabama
  • +39 more
Apr 24, 2015

Osteoarthritis Trial in United States (Meloxicam Test Capsules, Placebo Capsules)

Completed
  • Osteoarthritis
  • Meloxicam Test Capsules
  • Placebo Capsules
  • Birmingham, Alabama
  • +39 more
Mar 9, 2015

Osteoarthritis Trial in United States (gevokizumab)

Completed
  • Osteoarthritis
  • Tucson, Arizona
  • +27 more
Feb 17, 2015

Osteoarthritis Trial in United States (Diclofenac, Placebo)

Completed
  • Osteoarthritis
  • Phoenix, Arizona
  • +39 more
Apr 29, 2014

Osteoarthritis Trial in United States (Diclofenac)

Completed
  • Osteoarthritis
  • Phoenix, Arizona
  • +39 more
Apr 8, 2014

Pain, Osteoarthritis, Low Back Pain Trial in Worldwide (Tapentadol (CG5503) Extended Release (ER))

Completed
  • Pain
  • +2 more
  • Tapentadol (CG5503) Extended Release (ER)
  • Birmingham, Alabama
  • +147 more
Apr 24, 2014

Osteoarthritis Trial in United States (Placebo, gevokizumab)

Completed
  • Osteoarthritis
  • Huntsville, Alabama
  • +26 more
Mar 3, 2014

Osteoarthritis Trial in United States (Placebo, gevokizumab)

Completed
  • Osteoarthritis
  • Huntsville, Alabama
  • +22 more
Mar 3, 2014

Osteoarthritis, Chronic Pain Trial in United States (ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release),

Completed
  • Osteoarthritis
  • Chronic Pain
  • ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)
  • Placebo
  • Birmingham, Alabama
  • +80 more
Sep 13, 2013

Osteoarthritis, Rheumatoid Arthritis, Chronic Low Back Pain Trial in United States (HZT-501)

Completed
  • Osteoarthritis
  • +4 more
  • Chicago, Illinois
  • +3 more
Jun 19, 2013

Osteoarthritis Trial in Worldwide (Canakinumab, Placebo to canakinumab, Naproxen)

Completed
  • Osteoarthritis
  • Canakinumab
  • +3 more
  • Anniston, Alabama
  • +12 more
Sep 28, 2012

Osteoarthritis Trial in United States (Buprenorphine transdermal patch)

Terminated
  • Osteoarthritis
  • Buprenorphine transdermal patch
  • Alabaster, Alabama
  • +88 more
Sep 5, 2012

Osteoarthritis Trial in United States (Buprenorphine transdermal patch, Placebo transdermal patch)

Terminated
  • Osteoarthritis
  • Buprenorphine transdermal patch
  • Placebo transdermal patch
  • Birmingham, Alabama
  • +47 more
Aug 27, 2012

Osteoarthritis Trial in United States (Buprenorphine transdermal patch, Placebo)

Completed
  • Osteoarthritis
  • Buprenorphine transdermal patch
  • Placebo
  • Mesa, Arizona
  • +43 more
Aug 27, 2012

Osteoarthritis Trial in United States (Buprenorphine transdermal patch)

Completed
  • Osteoarthritis
  • Buprenorphine transdermal patch
  • Mesa, Arizona
  • +41 more
Aug 27, 2012

Osteoarthritis Trial in United States (ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System), Placebo Matrix/CHADD Patch,

Completed
  • Osteoarthritis
  • ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System)
  • +2 more
  • Peoria, Arizona
  • +35 more
May 17, 2012

Osteoarthritis Trial in United States (ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System))

Terminated
  • Osteoarthritis
  • ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System)
  • Anaheim, California
  • +19 more
Mar 14, 2012

Osteoarthritis, Hypertension Trial in United States (naproxcinod 375 mg -750 mg -1125 mg bid, naproxen 250 mg - 500mg -750 mg

Completed
  • Osteoarthritis
  • Hypertension
  • naproxcinod 375 mg -750 mg -1125 mg bid
  • naproxen 250 mg - 500mg -750 mg bid
  • Mobile, Alabama
  • +28 more
Jun 16, 2011

Osteoarthritis Trial in United States (Naproxcinod 375 mg bid, Naproxcinod 750 mg bid, Naproxen 500 mg bid)

Completed
  • Osteoarthritis
  • Naproxcinod 375 mg bid
  • +3 more
  • Chandler, Arizona
  • +72 more
Jun 16, 2011

Osteoarthritis Trial in United States (hydrocodone / acetaminophen extended release, Placebo)

Completed
  • Osteoarthritis
  • hydrocodone / acetaminophen extended release
  • Placebo
  • Birmingham, Alabama
  • +82 more
Jan 24, 2011

Osteoarthritis Trial in United States (LT-NS001, Naprosyn®)

Completed
  • Osteoarthritis
  • Birmingham, Alabama
  • +64 more
Jan 20, 2011